Terrence Connolly Founder of K36 Therapeutics Backed byAtlas VentureMichiel de Haan LinkedIn SourcesK36 Therapeutics Announces $70 Million Series B Financing to Fund Clinical Proof of Concept of KTX-1001, First-in-class Inhibitor of MMSET for Treatment of Multiple Myeloma Patients with Genetic Translocation (4;14) — 2023-06 Browse all founders · Browse investors
